Okay, let's tackle this question about the treatment of choice for Kawasaki disease. First, I need to recall what Kawasaki disease is. It's a systemic vasculitis that primarily affects children, and if untreated, can lead to coronary artery aneurysms. The mainstay of treatment is intravenous immunoglobulin (IVIG) and high-dose aspirin. The options here are missing, but the correct answer should be IVIG.

The core concept here is the standard therapy for Kawasaki disease. The key is that IVIG is the primary treatment, given in a single high dose. Aspirin is also used, but the question is about the treatment of choice, which is IVIG. So the correct answer would be IVIG.

Now, the wrong options might include other drugs like corticosteroids, antibiotics, or even other immunosuppressants. For example, if an option says "Corticosteroids," that's incorrect because while they might be used in some cases, IVIG is the first-line. Another wrong option could be "Antibiotics," which are not effective here since it's not an infection. Another might be "Acyclovir" or something else unrelated.

The clinical pearl here is that IVIG is given at 2 g/kg in a single infusion, and aspirin is started at high doses (80-100 mg/kg/day) and then tapered. Also, if a patient doesn't respond to the first IVIG dose, a second dose might be needed. Students should remember that IVIG is the gold standard and that aspirin is used for its anti-inflammatory and anticoagulant properties here.

I need to structure the explanation with the required sections. Core Concept: IVIG and aspirin. Why correct answer is right: IVIG's mechanism in reducing inflammation and preventing aneurysms. Why others are wrong: Corticosteroids not first-line, antibiotics ineffective. Clinical pearl: Dosing and timing. Correct Answer line.

**Core Concept**
Kawasaki disease is an acute systemic vasculitis in children treated with high-dose **intravenous immunoglobulin (IVIG)** and **aspirin** to reduce inflammation, prevent coronary artery aneurysms, and modulate immune response. IVIG targets immune complex-mediated vascular injury via Fc receptor blockade and cytokine suppression.

**Why the Correct Answer is Right**
IVIG (2 g/kg single infusion) is the first-line treatment, administered within 10 days of symptom onset to reduce coronary artery complications. It suppresses pro-inflammatory cytokines (e.g., IL-6, TNF-α), modulates T-cell activity, and neutralizes autoantibodies. Aspirin is added for its anti-inflammatory (initially 80-100 mg/kg/day) and anticoagulant (after fever resolves, 3-5 mg/kg/day) effects.

**Why Each Wrong Option is Incorrect**
**Option A:** *Corticosteroids* are not first-line; reserved for IVIG-resistant cases or adjunctive use in severe inflammation.
**Option B:** *Antibiotics* are ineffective as Kawasaki disease is immune-mediated, not infectious.
**Option C:** *Acyclovir* is irrelevant; no evidence supports antiviral therapy for this condition.

**Clinical Pearl / High-Yield Fact**
Remember **

✓ Correct Answer: A. IV immunoglobulin